Search
Profound Medical Corp
PROFAdd to Watchlist
6.870USD
+0.300+4.57%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
249.64MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-17The current earnings forecast score of Profound Medical Corp is 8.80, ranking 10 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 11.12, with a high of 12.00 and a low of 11.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
11.050
Target Price
+64.68%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Profound Medical Corp
PROF
5
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
34
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Profound Medical Corp's expected revenue for the next quarter?
Profound Medical Corp's expected revenue is 5.38M.
What is Profound Medical Corp's price target?
Analysts forecast that Profound Medical Corp's price target is USD 11.12, with the highest forecast at USD 12.00 and the lowest forecast at USD 11.00.
How have Profound Medical CorpPROF's recent earnings per share performed?
The market expectation was USD -0.19, while Profound Medical CorpPROF's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.24.
What is the analyst rating for Profound Medical Corp?
Based on the ratings of Profound Medical Corp's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
